Send Message

Drug Abuse Rapid Diagnostic Test Kits Buprenorphine BUP 10ng / Ml Panel

Basic Information
Place of Origin: China
Brand Name: AllTest
Certification: CE, ISO13485
Model Number: DBU-X14
Minimum Order Quantity: N/A
Price: Negotiation
Packaging Details: 25 cassette/box
Delivery Time: 2-4 Weeks
Payment Terms: Ex works
Supply Ability: 10 M tests/month
Format: AllTest Specimen: Powder
Kit Size: 10 T/Kit Storage: 2-30℃
Cut-off: 300ng/ml Certificate: CE
High Light:

rapid diagnostic test kits

,

one step rapid test

 

Drug Abuse Diagnosis Test Kit Buprenorphine ( BUP) 10ng/ml Panel Test high Precision Panel Powder With CE 

 

Application:

 

The buprenorphine Rapid Test Panel is a rapid chromatographic immunoassay for the qualitative detection of buprenorphine a cut-off 10ng/ml.
This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.

 

Description:  

 

Buprenorphine is a potent analgesic often used in the treatment of opioid addiction. The drug is sold under the trade names Subutex™, Buprenex™, Temgesic™ and Suboxone™, which contain Buprenorphine HCl alone or in combination with Naloxone HCl. Therapeutically, Buprenorphine is used as a substitution treatment for opioid addicts. Substitution treatment is a form of medical care offered to opiate addicts (primarily heroin addicts) based on a similar or identical substance to the drug normally used. In substitution therapy, Buprenorphine is as effective as Methadone but demonstrates a lower level of physical dependence.
The buprenorphine assay contained within the BUP Rapid Test Panel yields a positive result when the BUP concentration exceeds 10ng/ml.

 

How to use?

Test device (in closed pouches), samples, and controls should be brought to room temperature (15-30°C) prior to testing. Do not open pouches until ready to perform the assay.
Remove the test device from its protective pouch and label the device with patient’s identification or control label.
FOR SURFACES
1.Wipe with the panel over the surface in which the drugs are expected.
2. Take off the cap of supplied tube;
3. Fill all buffers from the supplied tube of buffer into the protection cover.
4. Insert the Multi Test slowly and carefully into the protection cover with buffer
5. Wait for lines to appear on the membrane and read the results after 5 minutes and do not interpret the result after 10 minutes.

Drug Abuse Rapid Diagnostic Test Kits Buprenorphine BUP 10ng / Ml Panel 0


FOR SOLIDS
1. Open the tube and put the solid in to the buffer.
2. Close the tube with dropper and cap. Shake it a short time. Wait for 30 sec.
3. Take off the cap of supplied tube;
4. Fill all buffers with dissolved substances into the protection cover.
5. Insert the Multi Test slowly and carefully into the protection cover with buffer.
6. Wait for lines to appear on the membrane and read the results after 5 minutes and do not interpret the result after 10 minutes.

Drug Abuse Rapid Diagnostic Test Kits Buprenorphine BUP 10ng / Ml Panel 1

 

 

INTERPRETATION OF RESULTS
(Please refer to the illustration above)
Drug Abuse Rapid Diagnostic Test Kits Buprenorphine BUP 10ng / Ml Panel 2

NEGATIVE:* A colored line appears in the Control region (C) and colored lines appear in the Test region (T). This negative result means that the concentrations in the sample are below the designated cut-off levels for a particular drug tested.


*NOTE: The shade of the colored lines(s) in the Test region (T) may vary. The result should be considered negative whenever there is even a faint line.

Drug Abuse Rapid Diagnostic Test Kits Buprenorphine BUP 10ng / Ml Panel 3

POSITIVE: A colored line appears in the Control region (C) and NO line appears in the Test region (T). The positive result means that the drug concentration in the sample is greater than the designated cut-off for a specific drug.


Drug Abuse Rapid Diagnostic Test Kits Buprenorphine BUP 10ng / Ml Panel 4

 

INVALID: No line appears in the Control region (C). Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for Control line failure. Read the directions again and repeat the test with a new test card. If the result is still invalid, contact your manufacturer.

Contact Details
selina

Phone Number : +8615857153722

WhatsApp : +8613989889852